A bio-psycho-socio-molecular approach to pain and stress management

Forschende Komplementarmedizin

Volumn 14, Issue 4, 2007, Pages 224-234

  Esch, T ^a,b   Stefano, G B ^b  

^a Department of Electrical Engineering and Computer Science   (Germany)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Autoregulation; Disease; Endocannabinoids; Integrative medicine; Mind body medicine; Morphine; Nitric oxide; Pain; Relaxation; Stress; Stress management

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID; HYDROCORTISONE; MORPHINE; NORADRENALIN;

ALZHEIMER DISEASE; ANALGESIA; AUTOREGULATION; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; COGNITIVE THERAPY; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEISURE; NERVE TRACT; PAIN; PARKINSON DISEASE; PHENOMENOLOGY; REVIEW; STRESS; STRESS MANAGEMENT;

ANIMALS; DOPAMINE; ENDOCANNABINOIDS; HUMANS; NEURAL PATHWAYS; OPIATE ALKALOIDS; OPIOID PEPTIDES; PAIN; RELAXATION TECHNIQUES; STRESS;

EID: 34548686589     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000105671     Document Type: Review

References (133)

1. Esch T, Stefano GB, Fricchione GL, Benson H: The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinol Lett 2002;23:199-208.
2. Stefano GB, Fricchione GL: The biology of deception: The evolution of cognitive coping as a denial-like process. Med Hypotheses 1995;44:311-314.
3. Esch T, Stefano GB, Fricchione GL, Benson H: Stress-related diseases: A potential role for nitric oxide. Med Sci Monit 2002;8:RA103-RA118.
4. Stefano GB, Fricchione GL: The biology of deception: Emotion and morphine. Med Hypotheses 1995;49:51-54.
5. Esch T, Stefano GB: An overview of stress and its impact in immunological diseases. Mod Asp Immunobiol 2002;2:187-192.
6. Esch T: [Health in stress: Change in the stress concept and its significance for prevention, health and life style]. Gesundheitswesen 2002;64:73-81.
7. Esch T, Stefano GB, Fricchione GL, Benson H: Stress in cardiovascular diseases. Med Sci Monit 2002;8:RA93-RA101.
8. Jones F, Bright J: Stress: Myth, Theory and Research. Harlow, Prentice Hall, 2001.
9. Stefano GB, Fricchione GL, Slingsby BT: Is stress stress? Placebo 2001;3:101-110.
10. Esch T, Stefano GB: Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Med Sci Monit 2002;8:1-9.
11. Esch T, Fricchione GL, Stefano GB: The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit 2003;9:RA23-RA34.
12. Stefano GB, Esch T, Cadet P, Zhu W, Mantione K, Benson H: Endocannabinoids as autoregulatory signaling molecules: Coupling to nitric oxide and a possible association with the relaxation response. Med Sci Monit 2003;9:RA63-RA75.
13. Stefano GB, Fricchione GL, Goumon Y, Esch T: Pain, immunity, opiate and opioid compounds and health. Med Sci Monit 2005;11:MS47-MS53.
14. Stefano GB, Benson H, Fricchione GL, Esch T (eds): The Stress Response: Always Good and When It Is Bad. New York, Medical Science International, 2005.
15. Stefano GB, Esch T: Integrative medical therapy: examination of meditation's therapeutic and global medicinal outcomes via nitric oxide. Int J Mol Med 2005;16:621-630.
16. Zochodne DW, Levy D: Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol 2005;51:255-267.
17. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, Giulivi C: The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem 2001;276:6945-6949.
18. De la Torre JC, Stefano GB: Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res Rev 2000;34:119-136.
19. Cadet P, Zhu W, Mantione K, Rymer M, Dardik I, Reisman S, Hagberg S, Stefano GB: Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int J Mol Med 2003;12:485-492.
20. Cannon WB: The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 1941;33:356-372.
21. Cannon WB: Bodily changes in pain, hunger, fear and rage: An account of recent researches into the function of emotional excitement New York, Appleton and Company, 1915.
22. Sterling P, Eyer J: Allostasis: A new paradigm to explain arousal pathology; in Fisher S, Reason J (eds): Handbook of Life, Stress, Cognition, and Health. New York, Wiley and Sons, 1998.
23. McEwen BS: Protective and damaging effects of stress mediation. New Engl J Med 1998;338:171-179.
24. Negrao AB, Deuster PA, Gold PW, Singh A, Chrousos GP: Individual reactivity and physiology of the stress response. Biomed Pharmacother 2000;54:122-128.
25. McCarty R, Gold PE: Catecholamines, stress, and disease: a psychobiological perspective. Psychosom Med 1996;58:590-597.
26. Brotto LA, Gorzalka BB, LaMarre AK: Melatonin protects against the effects of chronic stress on sexual behaviour in male rats. Neuroreport 2001;12:3465-3469.
27. Stefano GB: Endocannabinoid immune and vascular signaling. Acta Pharmacol Sin 2000;21:1071-1081.
28. Pryor SC, Zhu W, Cadet P, Bianchi E, Guarna M, Stefano GB: Endogenous morphine: opening new doors for the treatment of pain and addiction. Expert Opin Biol Ther 2005;5:893-906.
29. Zhu W, Ma Y, Bell A, Esch T, Guarna M, Bilfinger TV, Bianchi E, Stefano GB: Presence of morphine in rat amygdala: Evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit 2004;10:BR433-BR439.
30. Joseph JT, Cardozo DL: Functional Neuroanatomy: An Interactive Text and Manual. New York, Wiley-Liss, 2004.
31. Smith CM: Elements of Molecular Neurobiology, ed 3. New York, Wiley-Liss, 2002.
32. Stefano GB, Salzet M, Magazine HI, Bilfinger TV: Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 1998;31:813-820.
33. Stefano GB, Salzet M, Bilfinger TV: Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of Nitric Oxide. J Cardiovasc Pharmacol 1998;31:862-868.
34. Stefano GB, Salzet B, Salzet M: Identification and characterization of the leech CNS cannabinoid receptor: Coupling to nitric oxide release. Brain Res 1997;753:219-224.
35. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, Rialas C, Peter D, Sonetti D, Guarna M, Welters I, Bianchi E: Endogenous morphine. Trends Neurosci 2000;9:436-442.
36. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T: Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006;31:739-750.
37. Stefano GB: Endocannabinoid immune and vascular signaling. Acta Pharmacol Sin 2000;21:1071-1081.
38. Essick G, Guest S, Martinez E, Chen C, McGlone F: Site-dependent and subject-related variations in perioral thermal sensitivity. Somatosens Mot Res 2004;21:159-175.
39. Bostock H, Campero M, Serra J, Ochoa JL: Temperature-dependent double spikes in C-nociceptors of neuropathic pain patients. Brain 2005;128:2154-2163.
40. Jambrik Z, Santarcangelo EL, Rudisch T, Varga A, Forster T, Carli G: Modulation of pain-induced endothelial dysfunction by hypnotisability. Pain 2005;116:181-186.
41. Wu WP, Hao JX, Ongini E, Impagnatiello F, Presotto C, Wiesenfeld-Hallin Z, Xu XJ: A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury. Br J Pharmacol 2004;141:65-74.
42. Guyton AC, Hall JE: Textbook of Medical Physiology, ed 10. Philadelphia, WB Saunders, 2000.
43. Thomas A, Woolsey JH, Mokhtar HG: The Brain Atlas, ed 2. New York, Wiley, 2002.
44. Joseph JT, Cardozo DL: Functional Neuroanatomy: An interactive text and manual. New York, Wiley-Liss, 2004.
45. Stefano GB, Esch T, Cadet P, Zhu W, Mantione K, Benson H: Endocannabinoids as autoregulatory signaling molecules: Coupling to nitric oxide and a possible association with the relaxation response. Med Sci Monit 2003;9:RA63-75.
46. Esch T: Endocannabinoid signaling in stress, medicine and wellness. Med Sci Monit 2005;11:ED3-5.
47. Esch T, Michalsen A, Stefano GB: [Endocannabinoids as molecular instruments of health promotion]. Med Monatsschr Pharm 2006;29:397-403.
48. Stefano GB, Salzet B, Rialas CM, Pope M, Kustka A, Neenan K, et al: Morphine and anandamide stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 1997;763:63-8.
49. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HHO, Das SK, et al: Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 1997;100:1538-46.
50. Stefano GB: Comparative aspects of opioid-dopamine interaction. Cell Mol Neurobiol 1982;2:167-78.
51. Stefano GB: Role of opioid neuropeptides in immunoregulation. Prog Neurobiol 1989;33:149-59.
52. Stefano GB, Scharrer B, Smith EM, Hughes TK, Magazine HI, Bilfinger TV, et al: Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996;16:109-44.
53. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB: Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996;156:4845-50.
54. Deutsch DG, Chin SA: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 1993;46:791-6.
55. Deutsch DG, Omeir RL, Arreaza G, Salehani D, Prestwich GD, Huang Z, et al: Methyl arachidonyl flourophosphonate: A potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol 1997;53:255-60.
56. Omeir RL, Chin S, Hong Y, Ahern DG, Deutsch DG: Arachidonoyl ethanolamide-[1.2-14C] as a substrate for anandamide amidase. Life Sci 1995;56:1999-2005.
57. Stefano GB, Scharrer B, Smith EM, Hughes TK, Magazine HI, Bilfinger TV, Hartman A, Fricchione GL, Liu Y, Makman MH: Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996;16:109-144.
58. Stefano GB, Salzet M: Invertebrate opioid precursors: evolutionary conservation and the significance of enzymatic processing. Int Rev Cytol 1999;187:261-286.
59. Stefano GB, Salzet B, Fricchione GL: Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today 1998;19:265-268.
60. Esch T, Guarna M, Bianchi E, Zhu W, Stefano GB: Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit 2004;10:MS6-MS17.
61. Esch T, Stefano GB: The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinol Lett 2004;25:235-251.
62. Slingsby BT, Stefano GB: Placebo: Harnessing the power within. Mod Asp Immunobiol 2000;1:144-146.
63. Slingsby BT, Stefano GB: The active ingredients in the sugar pill: Trust and belief. Placebo 2001;2:33-38.
64. Stefano GB, Fricchione GL, Slingsby BT, Benson H: The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Res Brain Res Rev 2001;35:1-19.
65. Esch T, Stefano GB: The neurobiology of love. Neuroendocrinol Lett 2005;26:175-192.
66. Esch T, Stefano GB: Love promotes health. Neuroendocrinol Lett 2005;26:264-267.
67. Esch T, Kim JW, Stefano GB: Neurobiological implications of eating healthy. Neuroendocrinol Lett 2006;27:21-33.
68. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, Rialas C, Peter D, Sonetti D, Guarna M, Welters I, Bianchi E: Endogenous morphine. Trends Neurosci 2000;9:436-442.
69. Zhu W, Ma Y, Cadet P, Yu D, Bilfinger TV, Bianchi E, Stefano GB: Presence of reticuline in rat brain: A pathway for morphine biosynthesis. Mol Brain Res 2003;117:83-90.
70. Poeaknapo C, Schmidt J, Brandsch M, Dräger B, Zenk MH: Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 2004;101:14091-14096.
71. Zhu W, Cadet P, Baggerman G, Mantione KJ, Stefano GB: Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol 2005;175:7357-62.
72. Magazine HI, Chang J, Goumon Y, Stefano GB: Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J Immunol 2000;165:102-107.
73. Stefano GB, Salzet M, Bilfinger TV: Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of nitric oxide. J Cardiovasc Pharmacol 1998;31:862-868.
74. Stefano GB, Salzet M, Rialas C, Mattocks DW, Fimiani C, Bilfinger TV: Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int J Cardiol 1998;64:S3-S13.
75. Bianchi E, Guarna M, Tagliamonte A: Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol 1994;4:83-92.
76. Stefano GB, Cadet P, Zhu W, Rialas CM, Mantione K, Benz D, Fuentes R, Casares F, Fricchione GL, Fulop ZI, Slingsby BT: The blueprint for stress can be found in invertebrates. Neuroendocrinol Lett 2002;23:85-93.
77. Stefano GB, Scharrer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 1994;4:57-68.
78. Stefano GB, Cadet P, Dokun A, Scharrer B: A neuroimmunoregulatory-like mechanism responding to electrical shock in the marine bivalve Mytilus edulis. Brain Behav Immun 1990;4:323-329.
79. Bilfinger TV, Stefano GB: Evidence of immunocyte stimulatory molecules(s) in plasma of patients undergoing cardiopulmonary bypass. J Cardiovasc Surg 1993;34:129-133.
80. Reisine T, Pasternak GW: Opioid analgesics and antagonists; in Hardman JG, Limbird LE (eds): The pharmacological Basis of Therapeutics. New York, McGraw Hill, 1996.
81. Hnasko TS, Sotak BN, Palmiter RD: Morphine reward in dopamine-deficient mice. Nature 2005;438:854-857.
82. Zhu W, Mantione KJ, Shen L, Cadet P, Esch T, Goumon Y, Bianchi E, Sonetti D, Stefano GB: Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit 2005;11:BR397-BR404.
83. Stefano GB, Hall B, Makman MH, Dvorkin B: Opioid inhibition of dopamine release from nervous tissue of Mytilus edulis and Octopus bimaculatus. Science 1981;213:928-930.
84. Harvard Medical School: Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty, ed 3. Baltimore, Lippincott, Williams, and Wilkins, 2003.
85. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, Giulivi C: The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem 2001;276:6945-6949.
86. Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-1964.
87. Wu WP, Hao JX, Ongini E, Impagnatiello F, Presotto C, Wiesenfeld-Hallin Z, Xu XJ: A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury. Br. J Pharmacol 2004;141:65-74.
88. Stefano GB, Murga J, Benson H, Zhu W: Nitric oxide inhibits norepinephrine stimulated contraction of human internal thoracic artery and rat aorta. Pharmacol Res 2001;43:199-203.
89. Selye H: The evolution of the stress concept. Am Scientist 1973;61:692-699.
90. Esch T: Bestimmung von Vorgängen zum aktiven Erhalt der zellulären Autonomie und Organisation mit Hilfe des Schwesterchromatid- Austausch-Verfahrens [Dissertation]. Göttingen, Georg-August- Universität, 1999.
91. McEwen BS: Protective and damaging effects of stress mediators. New Engl J Med 1998;338:171-179.
92. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-1252.
93. Fricchione GL, Stefano GB: The stress response and autoimmunoregulation. Adv Neuroimmunol 1994;4:13-28.
94. Miller GE, Cohen S, Ritchey AK: Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002;21:531-541.
95. Krantz DS, Kop WJ, Santiago HT, Gottdiener JS: Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin 1996;14:271-287.
96. Phillips DP, Liu GC, Kwok K, Jarvinen JR, Zhang W, Abramson IS: The Hound of the Baskervilles effect: natural experiment on the influence of psychological stress on timing of death. BMJ 2001;323: 1443-1446.
97. Nguyen VH, McLaughlin MA: Coronary artery disease in women: a review of emerging cardiovascular risk factors. Mt Sinai J Med 2002;69:338-349.
98. Negrao AB, Deuster PA, Gold PW, Singh A, Chrousos GP: Individual reactivity and physiology of the stress response. Biomed Pharmacother 2000;54:122-128.
99. Skantze HB, Kaplan J, Pettersson K, Manuck S, Blomqvist N, Kyes R, Williams K, Bondjers G: Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation. Atherosclerosis 1998;136:153-161.
100. Kaplan JR, Manuck SB: Status, stress, and atherosclerosis: the role of environment and individual behavior. Ann NY Acad Sci 1999;896:145-161.
101. Castillo-Richmond A, Schneider RH, Alexander CN, Cook R, Myers H, Nidich S, Haney C, Rainforth M, Salerno J: Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000;31:568-573.
102. Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman RE, Hanson MM, Frid DJ, McNulty S, Morris JJ, O'Connor CM, et al: Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996; 275:1651-1656.
103. Sharpley CF: Psychosocial stress-induced heart rate reactivity and atherogenesis: cause or correlation? J Behav Med 1998;21:411-432.
104. Gullette EC, Blumenthal JA, Babyak M, Jiang W, Waugh RA, Frid DJ, O'Connor CM, Morris JJ, Krantz DS: Effects of mental stress on myocardial ischemia during daily life. JAMA 1997;277:1521-1526.
105. Manuck SB, Marsland AL, Kaplan JR, Williams JK: The pathogenicity of behavior and its neuroendocrine mediation: an example from coronary artery disease. Psychosom Med 1995;57:275-283.
106. Strawn WB, Bondjers G, Kaplan JR, Manuck SB, Schwenke DC, Hansson GK, Shively CA, Clarkson TE: Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 1991;68:1270-1279.
107. Yeung AC, Vekshtein VI, Krantz DS, Vita J, Ryan TJ Jr, Ganz P, Selwyn AP: The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. New Engl J Med 1991;325: 1551-1556.
108. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK: Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 1996;58:598-611.
109. Esch T: [The significance of stress for the cardiovascular system: Stress-associated cardiovascular diseases and non-pharmaceutical therapy options]. Apothekenmagazin 2003;21:8-15.
110. Richter WO, Sonnichsen AC, Schwandt P: Results and efficacy of public screening for hypercholesterolemia: The Bavarian Cholesterol Screening Project. J Clin Epidemiol 1995;48:1307-1313.
111. Komaroff AL (ed): Mind/ Body Medicine: A Special Health Report. Boston, Harvard Health Publications, 2001.
112. Esch T, Michalsen A, Stefano GB: [Endocannabinoids as molecular instruments of health promotion]. Med Monatsschr Pharm 2006;29:397-403.
113. Esch T: Stressmanagement - nicht nur um des Herzens willen. Comments on 'Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease' by Blumenthal J, et al, JAMA 2005: Forsch Komplementärmed 2006;13:119-121.
114. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, et al: Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280:2001-2007.
115. Stuart EM, Caudill M, Leserman J, Dorrington C, Friedman R, Benson H: Nonpharmacologic treatment of hypertension: a multiple-risk-factor approach. J Cardiovasc Nurs 1987;1:1-14.
116. Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A: Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med 2005;67:869-78.
117. Blumenthal JA, Sherwood A, Babyak MA, et al: Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA 2005;293:1626-34.
118. Sheps DS, Frasure-Smith N, Freedland KE, Carney RM: The INTERHEART study: Intersection between behavioral and general medicine. Psychosom Med 2004;66:797-8.
119. Stefano GB, Fricchione GL, Esch T: Relaxation: Molecular and physiological significance. Med Sci Monit 2006;12:HY21-31.
120. Salamon E, Esch T, Stefano GB: Pain and relaxation. Int J Mol Med 2006;18:465-70.
121. Stefano GB, Esch T: Integrative medical therapy: Examination of meditation's therapeutic and global medicinal outcomes via nitric oxide. Int J Mol Med 2005;16:621-30.
122. Dusek JA, Chang BH, Zaki J, Lazar S, Deykin A, Stefano GB, Wohlhueter AL, Hibberd PL, Benson H: Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit 2006;12:CR1-10.
123. Hoffman JW, Benson H, Arns PA, Stainbrook GL, Landsberg GL, Young JB, Gill A: Reduced sympathetic nervous system responsivity associated with the relaxation response. Science 1982;215:190-192.
124. Benson H: The relaxation response: Therapeutic effect. Science 1997;278:1693.
125. Benson H, Alexander S, Feldman CL: Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischaemic heart-disease. Lancet 1975;2:380-382.
126. Linden W: Autogenic training, a narrative and quantitative review of clinical outcome. Biofeedback Self Regul 1994;19:227-264.
127. van Dixhoorn JJ, Duivenvoorden HJ: Effect of relaxation therapy on cardiac events after myocardial infarction: a 5-year follow-up study. J Cardiopulm Rehabil 1999;19:178-185.
128. van Dixhoorn J, Duivenvoorden HJ, Pool J, Verhage F: Psychic effects of physical training and relaxation therapy after myocardial infarction. J Psychosom Res 1990;34:327-337.
129. Michalsen A, Grossman P, Acil A, Langhorst J, Ludtke R, Esch T, Stefano GB, Dobos GJ: Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Med Sci Monit 2005;11:CR555-561.
130. Esch T, Guarna M, Bianchi E, Stefano GB: Meditation and limbic processes. Biofeedback 2004;32:22-32.
131. Augustin M: [Alternative medicine therapy in dermatology: Dimensions, chances and approaches to an integrative understanding]. Forsch Komplementarmed 1999;6(suppl 2):1-4.
132. Hodgson DM, Nakamura T, Walker AK: Prophylactic role for complementary and alternative medicine in perinatal programming of adult health. Forsch Komplementarmed 2007;14:92-101.
133. Esch T: [Stress, adaptation, and self-organization: Balancing processes facilitate health and survival]. Forsch Komplementarmed 2003;10:330-341.